Mark Douglas Smith, Director: Jazz Pharmaceuticals JAZZ Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $266,746.35
Shares · price: 1,157 sh · $230.55 a share
Held after: 9,680 sh
Stock: Jazz Pharmaceuticals JAZZ
Person: Mark Douglas SmithDirector
Trade date: 26/06/15
Filed: 26/06/17
Days to filing: 2 days

Sold 10.7% of holdings

Share of holding sold: 10.7%

Jazz Pharmaceuticals trades, last 26 weeks

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/16~07/15

Mark Douglas Smith's recent trades

Mark Douglas SmithDirector
Planned saleJazz Pharmaceuticals
Planned sale
Jazz Pharmaceuticals
JAZZ
$857.6K
3,507 sh
$857.6K
Filed 08/31
Traded 08/31
Mark Douglas SmithDirector
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$266.7K
1,157 sh
$266.7K
Filed 06/15
Traded 06/15
Mark Douglas SmithDirector
Planned saleJazz Pharmaceuticals
Planned sale
Jazz Pharmaceuticals
JAZZ
$417.9K
3,731 sh
$417.9K
Filed 25/08/08
Traded 25/08/08
Mark Douglas SmithDirector
Sell10b5-1 planPhreesia
Sell10b5-1 plan
Phreesia
PHR
$203K
7,000 sh
$203K
Filed 25/07/03
Traded 25/07/02
Mark Douglas SmithDirector
Planned sale10b5-1 planPhreesia
Planned sale10b5-1 plan
Phreesia
PHR
$203K
7,000 sh
$203K
Filed 25/07/02
Traded 25/07/02